Protecting life-saving therapies: CPHI Online Podcast Series
The latest episode of the CPHI Podcast Series dives into a critical challenge facing the pharmaceutical industry: ensuring the integrity of temperature-sensitive medications and biologics through advanced predictive technology.
In this compelling episode, John and Laurie Masiello, co-founders of Predictive Monitor, sit down with CPHI Online to explore how their innovative solutions are transforming maintenance practices for refrigerated storage systems in the life sciences and biopharmaceutical sectors.
The Masiellos share their entrepreneurial journey in developing predictive maintenance and detection solutions specifically designed for an industry where storage failures can mean the difference between life and death. Their flagship product, Overshield, represents a fundamental shift away from traditional scheduled and reactive maintenance approaches that have long been the standard in pharmaceutical cold chain management.
"We're helping our clients protect and deliver life-saving products to the patients that need them most," the co-founders explain, highlighting the critical nature of their work in an industry where temperature excursions can compromise entire batches of vital medications.
As the pharmaceutical industry increasingly relies on temperature-sensitive biologics, cell and gene therapies, and mRNA-based treatments, the stakes for proper storage have never been higher. Equipment failures in refrigerated chamber systems can result in:
- Loss of expensive, life-saving inventory
- Delays in patient access to critical therapies
- Regulatory compliance issues
- Significant financial losses for manufacturers and distributors
Predictive technology offers a proactive solution, identifying potential equipment failures before they occur and enabling maintenance teams to intervene before products are compromised.
The episode provides listeners with practical insights into how predictive monitoring technology works in real-world pharmaceutical environments, offering a glimpse into the future of cold chain management where data-driven insights replace guesswork and reactive scrambling. This episode is essential listening for pharmaceutical manufacturers, cold chain logistics professionals, quality assurance teams, and anyone involved in the storage and distribution of temperature-sensitive healthcare products.
The CPHI Podcast Series delivers monthly insights from across the global pharmaceutical value chain, covering everything from drug discovery and development to manufacturing and delivery. Brought to you by the organisers of the CPHI and Pharmapack exhibitions, the series keeps industry professionals informed on the latest trends, developments, and opportunities shaping the future of pharma.
Access the full episode below.
Related News
-
News 2026 Outsourcing Outlook Update - pharma at a crossroads
The pharmaceutical contract development and manufacturing organisation (CDMO) sector is experiencing unprecedented transformation, driven by evolving therapeutic complexities, geopolitical tensions, and the growing demand for specialised manufacturing ... -
News Roche maintains German investment commitment whilst rivals scale back
Pharmaceutical giant Roche has reaffirmed its commitment to investing in Germany, standing firm even as competitors Eli Lilly and Boehringer Ingelheim dramatically reduce their planned investments in response to controversial healthcare reforms.
-
News Women in Pharma: The History of CPHI Women in Japan
Our monthly Women in Pharma series highlights the influential lives and work of impactful women working across the pharmaceutical industry, and how the industry can work towards making the healthcare industry and workplace more equitable and inclusive. -
News Tracking Innovation at CPHI Americas 2026 - Pfizer CentreOne
In this exclusive interview, Jim Donovan, VP and General Manager of Pfizer CentreOne, shares real-world insights on navigating the toughest challenges in ADC and biologics manufacturing: from high-containment conjugation and accelerated tech trans... -
News EU drafts deal to end essential medicines shortage
European negotiators have agreed new legislation to tackle persistent shortages of essential medicines by prioritising supply security over price in public procurement and supporting domestic pharmaceutical manufacturing with strategic funding.
-
News Thermo Fisher Scientific offloads microbiology business to PE firm Astorg
The life sciences giant is divesting its global microbiology unit, which generated $645 million in revenue last year, to the pan-European private equity firm as part of an active portfolio management strategy. The transaction is expected to close in th... -
News The Shift: Why Sustainability is Moving to the Centre of CPHI Milan 2026
CPHI Online contributor David Roach takes a look at how conversations around sustainability in the pharmaceutical industry can and must be transformed into actionable deliveries, and what the inaugural CPHI Sustainability Summit means for the industry. -
News Boehringer Ingelheim to invest in new AI Accelerator in London
Boehringer Ingelheim has unveiled a cutting-edge AI Accelerator in London’s Knowledge Quarter, marking a significant step in computational innovation and the future of pharmaceutical research.